Skip to main content
Caplight Logo









Nalu Bio

Nalu Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.nalubio.com/

Last Round

Series A

Feb 28, 2023

Total Funding Raised

$13.5M

Company Overview

Nalu Bio is a biotechnology company that has developed a drug discovery platform to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Sustainable Materials, Medical AI

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

synthetic cannabinoidscannabinoid ingredientslab-grown cannabinoidsTHC-free CBDcannabinoid synthesisCPG ingredientsendocannabinoid systemECSdrug discovery platformpharmaceutical ingredientsAI drug discoverynew chemical entitiesNCEs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nalu Bio Comparables

Compare Nalu Bio with similar companies based on industry and business-model similarity.

Nalu Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Creo
87%
Hyasynth Biologicals Inc.
82%
FloraWorks
77%

Nalu Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 28, 2023
SeedJan 7, 2021

Nalu Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 28, 2023

    $12M round led by Intrinsic Capital Partners.

Nalu Bio Filings

Explore SEC and related filing metadata, where available.

Nalu Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nalu Bio's valuation, stock price, and market status.

Is Nalu Bio a public or private company?

Nalu Bio is a private company.

What is the current stock price of Nalu Bio?

Nalu Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Nalu Bio worth (valuation)?

Valuation information for Nalu Bio is not publicly available.

Can I buy Nalu Bio stock?

Nalu Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nalu Bio's last funding round?

Nalu Bio's most recent funding round was Series A on February 28, 2023.

Who are the main investors in Nalu Bio?

Key investors in Nalu Bio include Intrinsic Capital Partners, L37 Ventures.

Will Nalu Bio IPO soon?

No public IPO plans have been announced for Nalu Bio.

How can I track Nalu Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nalu Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range12
Year Founded2019
Last FundingFeb 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?